ProShare Advisors
HCAT icon

ProShare Advisors’s Health Catalyst HCAT Stock Holding History

ProShare Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,357
Closed -$29.5K – 1945
2025
Q4 		$29.5K Buy
12,357
+793
+7% +$2.17K ﹤0.01% 2001
2025
Q3 		$33K Sell
11,564
-2,305
-17% -$7.89K ﹤0.01% 1964
2025
Q2 		$52.3K Buy
13,869
+915
+7% +$3.6K ﹤0.01% 1988
2025
Q1 		$58.7K Sell
12,954
-3,900
-23% -$20.6K ﹤0.01% 1929
2024
Q4 		$119K Buy
16,854
+5,815
+53% +$46.3K ﹤0.01% 2037
2024
Q3 		$89.9K Buy
+11,039
New +$79.8K ﹤0.01% 1898
2024
Q2 		– Sell
-10,259
Closed -$77.2K – 1913
2024
Q1 		$77.2K Buy
+10,259
New +$93.6K ﹤0.01% 1858
2022
Q2 		– Sell
-9,802
Closed -$256K – 1938
2022
Q1 		$256K Sell
9,802
-1,615
-14% -$45.8K ﹤0.01% 1748
2021
Q4 		$453K Buy
11,417
+4,989
+78% +$227K ﹤0.01% 1530
2021
Q3 		$321K Sell
6,428
-5,170
-45% -$282K ﹤0.01% 1495
2021
Q2 		$644K Buy
11,598
+2,608
+29% +$139K ﹤0.01% 1348
2021
Q1 		$420K Buy
8,990
+1,539
+21% +$74.5K ﹤0.01% 1558
2020
Q4 		$324K Buy
+7,451
New +$275K ﹤0.01% 1559

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors's HCAT Position: Q1 2026 in Review

ProShare Advisors sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 12,357 shares — an estimated $29.5K sold.

ProShare Advisors first reported a position in HCAT in Q4 2020 and held it in 13 quarters. The position peaked at $644K in Q2 2021. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • ProShare Advisors reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • ProShare Advisors sold 12,357 Health Catalyst shares in Q1 2026, an estimated $29.5K.
  • ProShare Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 13 quarters.
  • ProShare Advisors's Health Catalyst position peaked at $644K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.